↓ Skip to main content

Cochrane Database of Systematic Reviews

Endothelin receptor antagonists for subarachnoid hemorrhage

Overview of attention for article published in Cochrane database of systematic reviews, September 2012
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters
facebook
1 Facebook page
f1000
1 research highlight platform

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
82 Mendeley
Title
Endothelin receptor antagonists for subarachnoid hemorrhage
Published in
Cochrane database of systematic reviews, September 2012
DOI 10.1002/14651858.cd008354.pub2
Pubmed ID
Authors

Jia Guo, Zhenghong Shi, KeHu Yang, Jin Hui Tian, Lei Jiang

Abstract

A subarachnoid hemorrhage (SAH) is a serious and potentially life-threatening condition where blood leaks out of blood vessels over the surface of the brain. Delayed ischemic neurological deficit (DIND) and the related feature of vasospasm, where patients experience a delayed deterioration, have long been recognized as the leading potentially treatable cause of death and disability in patients with SAH. Endothelin is a potent, long-lasting endogenous vasoconstrictor that has been implicated in the pathogenesis of DIND. Therefore, endothelin receptor antagonists (ETAs) have emerged as a promising therapeutic option for SAH-induced cerebral vasospasm.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 82 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Canada 1 1%
Unknown 80 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 22%
Researcher 10 12%
Student > Postgraduate 9 11%
Student > Ph. D. Student 9 11%
Student > Bachelor 8 10%
Other 13 16%
Unknown 15 18%
Readers by discipline Count As %
Medicine and Dentistry 33 40%
Nursing and Health Professions 12 15%
Neuroscience 8 10%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Social Sciences 4 5%
Other 5 6%
Unknown 16 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 March 2016.
All research outputs
#9,385,834
of 17,067,437 outputs
Outputs from Cochrane database of systematic reviews
#9,107
of 11,628 outputs
Outputs of similar age
#77,009
of 159,853 outputs
Outputs of similar age from Cochrane database of systematic reviews
#57
of 83 outputs
Altmetric has tracked 17,067,437 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,628 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.6. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 159,853 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 83 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.